Senior/Principal Scientist – Pharmaceutical Development (Small Molecules)

Senior/Principal Scientist, Pharmaceutical Development (Small Molecules)💡 Ready to shape how novel small-molecule therapies move from idea to clinic?If you’re passionate about science, innovation, and building things as you go, this is your opportunity to play a key role in a fast-growing biotech where ideas turn into life-changing medicines.We’re looking for an experienced Senior or Principal Scientist to take scientific ownership of all pharmaceutical development activities for small molecule candidates — from preclinical formulation through early clinical manufacturing.You’ll join a team that thrives on curiosity and collaboration, where agility is part of the DNA and where “we lay the tracks as we go” isn’t just a motto — it’s a mindset.What You’ll DoDesign and optimize formulations for early clinical studies.Solve complex challenges like solubility and bioavailability using enabling technologies (solid dispersions, lipid-based systems, nano-milling, etc.).Drive CMC and production activities with partners across Europe and Asia.Prepare CMC documentation for clinical submissions (IMPD/IND).Collaborate cross-functionally — ensuring science, quality, and speed align.Who You AreYou’re a scientist at heart — someone who thrives in an environment of trust, autonomy, and innovation.You have:A Ph.D. or MSc in pharmacy, chemistry, or related field.10+ years in small molecule development, with strong formulation and CMC expertise.Experience leading outsourced activities and managing CDMOs.A proactive, adaptable mindset and fluent English communication.Why JoinImpact from Day One: You’ll see your decisions move projects forward — fast.Scientific Depth & Variety: Work across the full CMC lifecycle, not just a narrow slice.Collaborative Culture: Join a team that values initiative, trust, and open dialogue.Flexibility & Growth: High autonomy, competitive pay, and room to shape your role.Sounds like you? Let’s talk about how you can help shape the next generation of small-molecule innovation.